Animal-free recombinant antibodies from RevMAb Biosciences
RevMAb Biosciences USA, Inc has developed a revolutionary monoclonal antibody generation method. This method allowed the development of monoclonal antibodies without generation of hybridoma. The antibodies are developed from a broad range of antigen-specific B cells that are inaccessible to traditional hybridoma technology. This revolutionary method has enabled RevMAb to develop high quality rabbit and goat monoclonal antibodies.
Instead of current hybridoma generation by cell fusion methods, RevMAb expert scientists directly screen antibodies from immunized rabbit or goat B cells. RevMAb scientists can then clone cDNA and perform recombinant antibody production. Production is performed using transient and stable mammalian cell expression. Find out more about RevMAb and their available Services.
RevMAb Biosciences USA, Inc is located in heart of South San Francisco, the biotechnology hub of the Bay Area. The Bay Area is home to many of the largest and most successful biotechnology and pharmaceutical companies in the world.